19.23.2: Medications in the US System

Healthcare Interpreting · LibreTexts

0%

Contents

    Text

    Size
    100%
    Theme
    Typeface
    Line length
    Spacing

    Read aloud

    How

    Speed: 1×
    Light up
    Highlight

    Symbols: Mulberry Symbols, © 2018–2026 Steve Lee, CC BY-SA 4.0 (licence, the set), the site's own copies.

    From LibreTexts, under CC BY-NC 4.0, as the source states it; its equations are written in TeX, which the PDF shows typeset. This page at LibreTexts.

    19.23.2: Medications in the US System

    6. Medications Commonly Referenced in Rehabilitation Settings

    While therapists do not prescribe medications, they frequently discuss medications that impact function, pain, or mobility:

    Pain and inflammation:

    • Acetaminophen (Tylenol)clipboard_e59318fddb85387cbd1789b4032be8c77.png
    • Ibuprofen (Advil, Motrin)
    • Naproxen
    • Corticosteroids (oral or injections)

    Muscle relaxation and spasticity:

    • Baclofen
    • Cyclobenzaprine
    • Tizanidine

    Neuropathic pain:

    • Gabapentin
    • Pregabalin

    Interpreter note:
    Therapists may ask about side effects such as dizziness, fatigue, or weakness, as these affect therapy safety.

    7. U.S. Healthcare Context

    In the United States:

    • OT, PT, and SLP services often require provider referrals
    • Insurance coverage may limit number of visits
    • Therapy may occur in hospitals, outpatient clinics, rehabilitation centers, schools, or home health settings
    • Documentation and progress tracking are essential for continued authorization

    Understanding this system helps interpreters anticipate patient questions about visit limits, referrals, and care continuity.

    ✅ Key Takeaway

    Occupational therapy, physical therapy, and speech-language pathology play a critical role in helping patients regain independence and function. For interpreters, these encounters demand precision, flexibility, and strong situational awareness. Clear interpretation supports patient safety, therapy effectiveness, and trust within the rehabilitation team


    This page titled 19.23.2: Medications in the US System was last modified on Thu, 05 Nov 2026 01:45:09 GMT and is shared under a CC BY-NC 4.0 license and was authored, remixed, and/or curated by Sara Bradbury Máñez.